Skip to content

LifeSci IR

Investors
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs

LifeSci IR

Investors

Press Releases

Choose Year
Search Press Releases

Found 211 Results

December 11, 2017

Minerva Neurosciences Names Richard Russell President

December 6, 2017

Minerva Neurosciences Announces Enrollment of First Patient in Phase 2b Trial of Seltorexant (MIN-202) in Patients With Insomnia Disorder

November 8, 2017

Minerva Neurosciences to Present at Jefferies 2017 London Healthcare Conference on November 15, 2017

November 6, 2017

Minerva Neurosciences Reports Third Quarter 2017 Financial Results and Business Updates

October 31, 2017

Minerva Neurosciences Names Dr. Justine Lalonde as Senior Vice President, Product Strategy

October 30, 2017

Minerva Neurosciences to Report Third Quarter 2017 Financial Results and Business Updates on November 6, 2017

September 11, 2017

Minerva Neurosciences Names Dr. Jay Saoud as Senior Vice President, Head of Research and Development

September 5, 2017

Minerva Neurosciences Announces Enrollment of First Patient in Phase 2b Trial of Seltorexant (MIN-202) as Adjunctive Therapy in Patients With Major Depressive Disorder

August 25, 2017

Minerva Neurosciences Announces European Commission Approval of Amendment of MIN-202 Agreement With Janssen

August 3, 2017

Minerva Neurosciences Reports Second Quarter 2017 Financial Results and Business Updates

«...11 121314 15...20...»

IR Contact

FIRST NAME LAST NAME
COMPANY NAME
EMAIL@COMPANY.COM

Email Alerts Sign-Up

Email

I accept the Privacy Policy

Unsubscribe

Loading...

Copyright © 2026 LifeSci IR | Powered by Astra WordPress Theme

Scroll to Top